Abstract
Aiming to illustrate an innovation model in an emerging market, this case summarizes the successful launch of drug-eluting stents at MicroPort and the development of innovation capabilities and culture within the company. The case also demonstrates a strategic dilemma appearing after one round of effective technological innovation and, more importantly, how understanding the value system — in this case, the health care system — is key to sustaining innovation.
| Original language | English |
|---|---|
| Number of pages | 12 |
| Publication status | Published - 1 Jan 2012 |
Case number
GM-14-125Case normative number
GM-14-125-CECase type
FieldUpdate date
2016-07-03Published by
China Europe International Business SchoolKeywords
- Business model
- Healthcare
- Innovation
- Strategy
Case studies discipline
- General Management
- Strategy
Case studies industry
- Health Care Services